Emtricitabine Active Not Recruiting Phase 3 Trials for Pre-Exposure Prophylaxis of HIV-1 Infection Treatment

Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02842086Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection